Key facts
- This page summarizes Jeffrey R. Immelt's Form 4 filing for NeueHealth, Inc. (NEUE).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Oct 2025, 18:17.
Jeffrey R. Immelt - 02 Oct 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)
- Reporting relationship
- Director
- Issuer ticker
- NEUE
- Reported as of
- 02 Oct 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Oct 2025, 18:17:36 UTC
- Prior SEC filing
- 02 Oct 2025
- Next SEC filing
- 17 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Halverson for Jeffrey R. Immelt, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey R. Immelt filed Form 4 for NeueHealth, Inc. (NEUE) on 06 Oct 2025.
Change
- Previous filing in this sequence was filed on 02 Oct 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001233164
Primary reporting owner
IMMELT JEFFREY R
- Relationship
- Director
- Address
- C/O NEUEHEALTH, INC., 9250 NW 36TH ST SUITE 420, DORAL
- Signature
- /s/ Eric Halverson for Jeffrey R. Immelt, Attorney-in-Fact
- Signature date
- 06 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEUE
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -23,918
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 02 Oct 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Jeffrey R. Immelt is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc.
Footnote F2
Pursuant to the Rollover Agreement, dated as of September 23, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").